Daily as of 3 Nov 16:00 ET
- Price
- above both $248.93 vs 50 $228.34 / 200 $202.00
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 25 Sep 2025 · projected 28 bars out · tested 3 bars
BIIB | BiogenNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$248.93
-$0.08 (-0.03%)
Biogen (BIIB) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Sep 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a golden cross is projected within 10 bars.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $253.62 vs 50 $197.71 / 200 $205.35
- Projection
- 🟨Golden cross projected in 5 bars
- Test
- No active test
- Last cross
- 💀Death cross week of 4 Mar 2024 · projected 10 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- above both $250.61 vs 50 $236.35 / 200 $216.84
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 7 May 2026 · projected 11 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 7 May 2026 | 🟨Golden | 4-hour | 11 bars out | Not tested |
| 1 May 2026 | 💀Death | 4-hour | 2 bars out | Not tested |
| 29 Apr 2026 | 🟨Golden | 4-hour | 26 bars out | Not tested |
| 17 Apr 2026 | 💀Death | 4-hour | 16 bars out | 2 bar cross test |
| 25 Sep 2025 | 🟨Golden moderate | daily | 28 bars out | 3 bar cross test |
About BIIB
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$203M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge